Literature DB >> 15480130

A randomized clinical trial of manipulative therapy and interferential therapy for acute low back pain.

Deirdre A Hurley1, Suzanne M McDonough, Martin Dempster, Ann P Moore, G David Baxter.   

Abstract

STUDY
DESIGN: A multicenter assessor-blinded randomized clinical trial was conducted.
OBJECTIVES: To investigate the difference in effectiveness of manipulative therapy and interferential therapy for patients with acute low back pain when used as sole treatments and in combination. SUMMARY OF BACKGROUND DATA: Both manipulative therapy and interferential therapy are commonly used treatments for low back pain. Evidence for the effectiveness of manipulative therapy is available only for the short-term. There is limited evidence for interferential therapy, and no study has investigated the effectiveness of manipulative therapy combined with interferential therapy.
METHODS: Consenting subjects (n = 240) recruited following referral by physicians to physiotherapy departments in the (government-funded) National Health Service in Northern Ireland were randomly assigned to receive a copy of the Back Book and either manipulative therapy (MT; n = 80), interferential therapy (IFT; n = 80), or a combination of manipulative therapy and interferential therapy (CT; n = 80). The primary outcome was a change in functional disability on the Roland Morris Disability Questionnaire. Follow-up questionnaires were posted at discharge and at 6 and 12 months.
RESULTS: The groups were balanced at baseline for low back pain and demographic characteristics. At discharge all interventions significantly reduced functional disability (Roland Morris scale, MT: -4.53; 95% CI, -5.7 to -3.3 vs. IFT: -3.56; 95% CI, -4.8 to -2.4 vs. CT: -4.65; 95% CI, -5.8 to -3.5; P = 0.38) and pain (McGill questionnaire, MT: -5.12; 95% CI, -7.7 to -2.5 vs. IFT: -5.87; 95% CI, -8.5 to -3.3 vs. CT: -6.64; 95% CI, -9.2 to -4.1; P = 0.72) and increased quality of life (SF-36 Role-Physical, MT: 28.6; 95% CI, 18.3 to 38.9 vs. IFT: 31.4; 95% CI, 21.2 to 41.5 vs. CT: 30; 95% CI, 19.9 to 40; P = 0.93) to the same degree and maintained these improvements at 6 and 12 months. No significant differences were found between groups for reported LBP recurrence, work absenteeism, medication consumption, exercise participation, or healthcare use at 12 months (P > 0.05).
CONCLUSIONS: For acute low back pain, there was no difference between the effects of a combined manipulative therapy and interferential therapy package and either manipulative therapy or interferential therapy alone.

Entities:  

Mesh:

Year:  2004        PMID: 15480130     DOI: 10.1097/01.brs.0000142234.15437.da

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  14 in total

1.  Effect sizes of non-surgical treatments of non-specific low-back pain.

Authors:  A Keller; J Hayden; C Bombardier; M van Tulder
Journal:  Eur Spine J       Date:  2007-07-10       Impact factor: 3.134

2.  Physiotherapy and low back pain in the injured worker: an examination of current practice during the subacute phase of healing.

Authors:  Katherine Harman; Anne Fenety; Alison Hoens; James Crouse; Bev Padfield
Journal:  Physiother Can       Date:  2009-05-12       Impact factor: 1.037

3.  National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy.

Authors:  Mette Jensen Stochkendahl; Per Kjaer; Jan Hartvigsen; Alice Kongsted; Jens Aaboe; Margrethe Andersen; Mikkel Ø Andersen; Gilles Fournier; Betina Højgaard; Martin Bach Jensen; Lone Donbæk Jensen; Ture Karbo; Lilli Kirkeskov; Martin Melbye; Lone Morsel-Carlsen; Jan Nordsteen; Thorvaldur Skuli Palsson; Zoreh Rasti; Peter Frost Silbye; Morten Zebitz Steiness; Simon Tarp; Morten Vaagholt
Journal:  Eur Spine J       Date:  2017-04-20       Impact factor: 3.134

Review 4.  Prediction of sickness absence in patients with chronic low back pain: a systematic review.

Authors:  Wietske Kuijer; Johan W Groothoff; Sandra Brouwer; Jan H B Geertzen; Pieter U Dijkstra
Journal:  J Occup Rehabil       Date:  2006-09

Review 5.  Non-Specific Low Back Pain.

Authors:  Jean-François Chenot; Bernhard Greitemann; Bernd Kladny; Frank Petzke; Michael Pfingsten; Susanne Gabriele Schorr
Journal:  Dtsch Arztebl Int       Date:  2017-12-25       Impact factor: 5.594

6.  Physiotherapy for sleep disturbance in chronic low back pain: a feasibility randomised controlled trial.

Authors:  Deirdre A Hurley; Jennifer Eadie; Grainne O'Donoghue; Clare Kelly; Chris Lonsdale; Suzanne Guerin; Mark A Tully; Willem van Mechelen; Suzanne M McDonough; Colin A G Boreham; Conor Heneghan; Leslie Daly
Journal:  BMC Musculoskelet Disord       Date:  2010-04-16       Impact factor: 2.362

7.  A literature review reveals that trials evaluating treatment of non-specific low back pain use inconsistent criteria to identify serious pathologies and nerve root involvement.

Authors:  Ciaran Williams; Mark J Hancock; Manuela Ferreira; Paulo Ferreira; Chris G Maher
Journal:  J Man Manip Ther       Date:  2012-05

8.  A pilot randomized controlled trial comparing the efficacy of exercise, spinal manipulation, and neuro emotional technique for the treatment of pregnancy-related low back pain.

Authors:  Caroline D Peterson; Mitchell Haas; W Thomas Gregory
Journal:  Chiropr Man Therap       Date:  2012-06-13

9.  A walking programme and a supervised exercise class versus usual physiotherapy for chronic low back pain: a single-blinded randomised controlled trial. (The Supervised Walking In comparison to Fitness Training for Back Pain (SWIFT) Trial).

Authors:  Deirdre A Hurley; Grainne O'Donoghue; Mark A Tully; Jennifer Klaber Moffett; Willem van Mechelen; Leslie Daly; Colin Ag Boreham; Suzanne M McDonough
Journal:  BMC Musculoskelet Disord       Date:  2009-07-02       Impact factor: 2.362

10.  Research priorities for non-pharmacological therapies for common musculoskeletal problems: nationally and internationally agreed recommendations.

Authors:  Nadine E Foster; Krysia S Dziedzic; Danielle A W M van der Windt; Julie M Fritz; Elaine M Hay
Journal:  BMC Musculoskelet Disord       Date:  2009-01-09       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.